Reduced FSH and LH Action: Implications for Medically Assisted Reproduction

Overview

Journal Hum Reprod

Publisher Oxford University Press

Specialty Reproductive Medicine

Date 2021 Apr 1

PMID 33792685

Citations 35

Authors

E Bosch

C Alviggi

M Lispi

A Conforti

A C Hanyaloglu

D Chuderland

M Simoni

N Raine-Fenning

P Crepieux

S Kol

V Rochira

T DHooghe

P Humaidan

Affiliations

Soon will be listed here.

Abstract

Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) play complementary roles in follicle development and ovulation via a complex interaction in the hypothalamus, anterior pituitary gland, reproductive organs, and oocytes. Impairment of the production or action of gonadotropins causes relative or absolute LH and FSH deficiency that compromises gametogenesis and gonadal steroid production, thereby reducing fertility. In women, LH and FSH deficiency is a spectrum of conditions with different functional or organic causes that are characterized by low or normal gonadotropin levels and low oestradiol levels. While the causes and effects of reduced LH and FSH production are very well known, the notion of reduced action has received less attention by researchers. Recent evidence shows that molecular characteristics, signalling as well as ageing, and some polymorphisms negatively affect gonadotropin action. These findings have important clinical implications, in particular for medically assisted reproduction in which diminished action determined by the afore-mentioned factors, combined with reduced endogenous gonadotropin production caused by GnRH analogue protocols, may lead to resistance to gonadotropins and, thus, to an unexpected hypo-response to ovarian stimulation. Indeed, the importance of LH and FSH action has been highlighted by the International Committee for Monitoring Assisted Reproduction Technologies (ICMART) in their definition of hypogonadotropic hypogonadism as gonadal failure associated with reduced gametogenesis and gonadal steroid production due to reduced gonadotropin production or action. The aim of this review is to provide an overview of determinants of reduced FSH and LH action that are associated with a reduced response to ovarian stimulation.

Citing Articles

The role of recombinant LH in ovarian stimulation: what's new?.

Alviggi C, Vigilante L, Cariati F, Conforti A, Humaidan P Reprod Biol Endocrinol. 2025; 23(Suppl 1):38.

PMID: 40059197 PMC: 11892182. DOI: 10.1186/s12958-025-01361-8.

Pharmacogenomic of LH and its receptor: are we ready for clinical practice?.

Conforti A, Di Girolamo R, Guida M, Alviggi C, Casarini L Reprod Biol Endocrinol. 2025; 23(Suppl 1):29.

PMID: 40001128 PMC: 11863420. DOI: 10.1186/s12958-025-01359-2.

Effects of 100 IU versus 150 IU hCG supplementation on oocyte and embryo quality in patients aged ≥ 35 years: a propensity score-matched analysis.

Huong N, Thuy T, Anh P, Long H, Thang L, Ngoc V Int J Med Sci. 2025; 22(4):982-989.

PMID: 39991766 PMC: 11843143. DOI: 10.7150/ijms.106965.

Hormonal Status and Quality of Life of Women Treated for Infertility Before and During COVID-19 Pandemic in Poland.

Wojtowicz K, Kot J, Makara-Studzinska M, Wdowiak N, Filip M, Wrobel A J Clin Med. 2025; 14(3).

PMID: 39941391 PMC: 11818197. DOI: 10.3390/jcm14030721.

The role of LH in follicle development: from physiology to new clinical implications.

Longo M, Liuzzi F, De Carlini S, La Marca A Reprod Biol Endocrinol. 2025; 23(Suppl 1):22.

PMID: 39930391 PMC: 11808943. DOI: 10.1186/s12958-025-01353-8.

References

Sposini S, Jean-Alphonse F, Ayoub M, Oqua A, West C, Lavery S . Integration of GPCR Signaling and Sorting from Very Early Endosomes via Opposing APPL1 Mechanisms. Cell Rep. 2017; 21(10):2855-2867. PMC: 5732320. DOI: 10.1016/j.celrep.2017.11.023. View

Riccetti L, De Pascali F, Gilioli L, Santi D, Brigante G, Simoni M . Genetics of gonadotropins and their receptors as markers of ovarian reserve and response in controlled ovarian stimulation. Best Pract Res Clin Obstet Gynaecol. 2017; 44:15-25. DOI: 10.1016/j.bpobgyn.2017.04.002. View

Jean-Alphonse F, Bowersox S, Chen S, Beard G, Puthenveedu M, Hanyaloglu A . Spatially restricted G protein-coupled receptor activity via divergent endocytic compartments. J Biol Chem. 2013; 289(7):3960-77. PMC: 3924264. DOI: 10.1074/jbc.M113.526350. View

Wang P, Protheroe A, Clarkson A, Imhoff F, Koishi K, McLennan I . Müllerian inhibiting substance contributes to sex-linked biases in the brain and behavior. Proc Natl Acad Sci U S A. 2009; 106(17):7203-8. PMC: 2678437. DOI: 10.1073/pnas.0902253106. View

Latronico A, Chai Y, Arnhold I, Liu X, Mendonca B, Segaloff D . A homozygous microdeletion in helix 7 of the luteinizing hormone receptor associated with familial testicular and ovarian resistance is due to both decreased cell surface expression and impaired effector activation by the cell surface receptor. Mol Endocrinol. 1998; 12(3):442-50. DOI: 10.1210/mend.12.3.0077. View

Filicori M, Cognigni G, Pocognoli P, Ciampaglia W, Bernardi S . Current concepts and novel applications of LH activity in ovarian stimulation. Trends Endocrinol Metab. 2003; 14(6):267-73. DOI: 10.1016/s1043-2760(03)00085-7. View

Casarini L, Riccetti L, De Pascali F, Nicoli A, Tagliavini S, Trenti T . Follicle-stimulating hormone potentiates the steroidogenic activity of chorionic gonadotropin and the anti-apoptotic activity of luteinizing hormone in human granulosa-lutein cells in vitro. Mol Cell Endocrinol. 2015; 422:103-114. DOI: 10.1016/j.mce.2015.12.008. View

Schuring A, Busch A, Bogdanova N, Gromoll J, Tuttelmann F . Effects of the FSH-β-subunit promoter polymorphism -211G->T on the hypothalamic-pituitary-ovarian axis in normally cycling women indicate a gender-specific regulation of gonadotropin secretion. J Clin Endocrinol Metab. 2012; 98(1):E82-6. DOI: 10.1210/jc.2012-2780. View

Rull K, Grigorova M, Ehrenberg A, Vaas P, Sekavin A, Nommemees D . FSHB -211 G>T is a major genetic modulator of reproductive physiology and health in childbearing age women. Hum Reprod. 2018; 33(5):954-966. DOI: 10.1093/humrep/dey057. View

10.

Pau K, Berria M, Hess D, Spies H . Preovulatory gonadotropin-releasing hormone surge in ovarian-intact rhesus macaques. Endocrinology. 1993; 133(4):1650-6. DOI: 10.1210/endo.133.4.8404606. View

11.

Lyga S, Volpe S, Werthmann R, Gotz K, Sungkaworn T, Lohse M . Persistent cAMP Signaling by Internalized LH Receptors in Ovarian Follicles. Endocrinology. 2016; 157(4):1613-21. DOI: 10.1210/en.2015-1945. View

12.

Griesinger G, Shapiro D . Luteinizing hormone add-back: is it needed in controlled ovarian stimulation, and if so, when?. J Reprod Med. 2011; 56(7-8):279-300. View

13.

Bianco S, Kaiser U . The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat Rev Endocrinol. 2009; 5(10):569-76. PMC: 2864719. DOI: 10.1038/nrendo.2009.177. View

14.

Conn P, Crowley Jr W . Gonadotropin-releasing hormone and its analogs. Annu Rev Med. 1994; 45:391-405. DOI: 10.1146/annurev.med.45.1.391. View

15.

Jonas K, Chen S, Virta M, Mora J, Franks S, Huhtaniemi I . Temporal reprogramming of calcium signalling via crosstalk of gonadotrophin receptors that associate as functionally asymmetric heteromers. Sci Rep. 2018; 8(1):2239. PMC: 5797151. DOI: 10.1038/s41598-018-20722-5. View

16.

Huirne J, van Loenen A, Schats R, Mcdonnell J, Hompes P, Schoemaker J . Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy. Hum Reprod. 2004; 20(2):359-67. DOI: 10.1093/humrep/deh601. View

17.

Zumoff B, Strain G, Miller L, Rosner W . Twenty-four-hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab. 1995; 80(4):1429-30. DOI: 10.1210/jcem.80.4.7714119. View

18.

Zarinan T, Butnev V, Gutierrez-Sagal R, Maravillas-Montero J, Martinez-Luis I, Mejia-Dominguez N . In Vitro Impact of FSH Glycosylation Variants on FSH Receptor-stimulated Signal Transduction and Functional Selectivity. J Endocr Soc. 2020; 4(5):bvaa019. PMC: 7175721. DOI: 10.1210/jendso/bvaa019. View

19.

Mol B, Bossuyt P, Sunkara S, Garcia Velasco J, Venetis C, Sakkas D . Personalized ovarian stimulation for assisted reproductive technology: study design considerations to move from hype to added value for patients. Fertil Steril. 2018; 109(6):968-979. DOI: 10.1016/j.fertnstert.2018.04.037. View

20.

Barrenetxea G, Agirregoikoa J, Jimenez M, de Larruzea A, Ganzabal T, Carbonero K . Ovarian response and pregnancy outcome in poor-responder women: a randomized controlled trial on the effect of luteinizing hormone supplementation on in vitro fertilization cycles. Fertil Steril. 2007; 89(3):546-53. DOI: 10.1016/j.fertnstert.2007.03.088. View